Page 425 - Multidisipliner Covid 19

COVID-19 ve Endokrin Sistem Hastal›klar›

8. Pal R, Banerjee M. COVID-19 and the endocrine system: exploring
the unexplored. J Endocrinol Invest. 2020:1-5. doi: 10.1007/s40618-
020-01276-8.
9. Pal R, Bhadada SK. COVID-19 and diabetes mellitus: An unholy inter-
action of two pandemics. Diabetes Metab Syndr. 2020;14(4):513-517.
doi: 10.1016/j.dsx.2020.04.049.
10. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics,
Comorbidities, and Outcomes Among 5700 Patients Hospitalized With
COVID-19 in the New York City Area. JAMA. 2020;323(20):2052-9. doi:
10.1001/jama.2020.6775.
11. Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and Thrombotic
or Thromboembolic Disease: Implications for Prevention, Antithrom-
botic Therapy, and Follow-up. J Am Coll Cardiol. 2020:S0735-1097(20)
35008-7. doi: 10.1016/j.jacc.2020.04.031.
12. Poissy J, Goutay J, Caplan M, et al, Lille ICU Haemostasis COVID-19
group. Pulmonary Embolism in COVID-19 Patients: Awareness of an
Increased Prevalence. Circulation. 2020. 10.1161/CIRCULATIONAHA.
120.047430.
13. Guo W, Li M, Dong Y, et al. Diabetes is a risk factor for the progression
and prognosis of COVID-19. Diabetes Metab Res Rev. 2020:e3319. doi:
10.1002/dmrr.3319.
14. Li B, Yang J, Zhao F, et al. Prevalence and Impact of Cardiovascular
Metabolic Diseases on COVID-19 in China. Clin Res Cardiol. 2020;
109(5):531-538. doi: 10.1007/s00392-020-01626-9.
15. Fadini GP, Morieri ML, Longato E, Avogaro A. Prevalence and impact
of diabetes among people infected with SARS-CoV-2. J Endocrinol
Invest. 2020;43(6):867-869. doi: 10.1007/s40618-020-01236-2.
16. Guan WJ, Ni ZY, Hu Y, et al, China Medical Treatment Expert Group
for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in
China. N Engl J Med. 2020;382(18):1708-1720. doi: 10.1056/NEJMoa
2002032.
17. Wu Z, McGoogan JM. Characteristics of and Important Lessons From
the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary
of a Report of 72_314 Cases From the Chinese Center for Disease Con-
trol and Prevention. JAMA. 2020. doi: 10.1001/jama.2020.2648.
18. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics
of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020. doi:

424